We previously reported that short-term immobilization stress of rats causes increased colonic mucin release, goblet cell depletion, prostaglandin E2 secretion, and colonic mast cell activation, as well as increased colonic motility. The purpose of this study was to investigate whether neurotensin (NT), a peptide expressed in both brain and digestive tract, participates in these responses. Rats were pretreated with SR 48692 (1 mg/kg, i.p.), an NT antagonist, 15 min before immobilization (30 min). The administration of the antagonist significantly inhibited stress-mediated secretion of colonic mucin, prostaglandin E2, and a product of rat mast cells, rat mast cell protease II (P < 0.05), but did not alter the increase in fecal pellet output caused by immobilization stress. Immobilization stress also resulted in a quantifiable decrease in the abundance of NT receptor mRNA in rat colon compared with that in colonic tissues from nonimmobilized rats as measured by densitometric analysis of in situ hybridization studies (P < 0.03). We conclude that the peptide NT is involved in colonic goblet cell release and mucosal mast cell activation after immobilization stress.
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Neurotensin (NT), a 13-aa peptide originally isolated by Carraway and Leeman (1, 2) , has a broad but discrete localization throughout the central nervous system and the digestive tract of animals and humans (2) (3) (4) . NT has been identified in specific endocrine cells, named N-cells, in the ileal mucosa of dogs (5) and humans (6) . The known intestinal effects of NT include stimulation of growth of small and large bowel, pancreas, and stomach (7) (8) (9) ; stimulation of small intestinal secretion (10) ; inhibition of small bowel and gastric motility (11) ; and stimulation of colonic motor activity (12) . It is well-established that restraint of animals stimulated motility of the large intestine, as measured by colonic transit and fecal pellet output (13, 14) . We recently reported that restraint of rats causes increased mucin release, as measured by [3H] glucosamine incorporation and goblet cell depletion, prostaglandin E2 (PGE2) secretion, and mast cell activation in colonic explants (15) .
A number of observations suggest that NT may participate in stress-related responses. For example, central administration of NT in freely moving rats stimulates release of adrenocorticotropin hormone and corticosterone levels (16) (17) (18) , indicating that it may be involved in the regulation of hypothalamic-pituitary-adrenal axis activity. Ceccatelli et al. also showed up-regulation of the NT precursor mRNA in the paraventricular nucleus of the hypothalamus after immobilization stress (19) .
Augeron et al. (20) reported that NT stimulates mucin secretion from a human colonic goblet cell line by a receptormediated mechanism. Because our data showed that immobilization stress also stimulated colonic goblet cell degranulation and mucin secretion from rat colon (15), we postulated that NT is involved in colonic mucin secretion as well in other colonic responses after immobilization stress.
An important advance in the field of NT research has been the development of the potent, highly specific, nonpeptide NT receptor antagonist SR 48692, which inhibits NT binding and functional effects of NT (21, 22 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 5%/95% C02/02 atmosphere. After 18 h, the medium was aspirated and trichloroacetic acid or phosphotungstic acid (Sigma) was added to a final concentration of 10% and 1%, respectively. Glycoproteins were allowed to precipitate overnight at 4°C. The mixture was then centrifuged (1600 x g for 30 min at 4°C), and the pellet was resuspended in cold trichloroacetic acid or phosphotungstic acid and centrifuged again. This washing step was repeated three times to ensure complete removal of unincorporated [3H]glucosamine. The final pellet was dissolved in 1 ml of 0.3 M NaOH. Samples were neutralized with 0.1 ml of 0.6 M acetic acid, and radioactivity was measured by scintillation counting. In some samples, to confirm that [3H]glucosamine was incorporated into mucin, the trichloroacetic acid or phosphotungstic acid precipitate was examined by density gradient ultracentrifugation as described (24, 25) .
Mucin secretion was also estimated in histological sections by counting the number of goblet cells depleted of mucin. Colonic samples obtained at the end of the 30-min immobilization stress were fixed in formalin, paraffin-embedded, and stained with hematoxylin and eosin, and Alcian blue. For each sample, the number of goblet cells containing mucus was estimated in an area that included 10 parallel colonic crypts. Because previous results from our laboratory indicated that immobilization stress reduces the number of surface, but not crypt, goblet cells (15), we restricted our measurements to the surface goblet cells only. Sections were examined in a blinded fashion by a gastrointestinal pathologist (S.N.), and results were expressed as the number of goblet cells containing mucin per 100 colonic surface epithelial cells.
Measurement of PGE2 and RMCPII. Mucosal explants (three sections per dish) were incubated (at 37°C for 30 min) in 1 ml of modified Kreb's buffer (26) . After 30 min, the medium was replaced with fresh medium, and explants were incubated for an additional 2 h at 37°C. RMCPII and PGE2 were measured in 100-,ul aliquots of the supernatants. RMC-PII was measured by a sandwich ELISA kit (MORENDUN Animal Health LTD, Edinburgh) as we described previously (27, 28) as compared with controls ( Fig. 2 and Table 1 ), consistent with our previous observation (15) . Pretreatment of rats with the NT antagonist SR 48692 15 min before immobilization stress significantly inhibited mucin release from cultured colonic explants ( Fig. 1 , P < 0.05). In nonstressed animals, pretreatment with SR 48692 (1 mg/kg, i.p., n = 4) had no significant effect on basal levels of colonic mucin (12,060 ± 180 dpm/mg protein) as compared with levels of vehicle-injected control animals (11,750 ± 520 dpm/mg protein). Further confirmation of inhibition of stress-mediated mucin secretion by the NT antagonist was observed histologically. Treatment with SR 48692 inhibited the reduction in the number of surface goblet cells containing mucin ( Fig. 2 and Table 1 ).
Inhibition by the NT Antagonist on Stress-Mediated PGE2 and RMCPII Release. Thirty minutes of immobilization stress resulted in a 2.3-fold and 7.1-fold increase in PGE2 (Fig. 3) and RMCPII (Fig. 4) , respectively. Pretreatment with the NT antagonist significantly inhibited stress-mediated PGE2 (Fig.  3 , P < 0.05) and RMCPII release (Fig. 4 , P < 0.05). In nonstressed animals, pretreatment with SR 48692 (1 mg/kg, i.p., n = 4) had no significant effect on basal levels of colonic PGE2 (10.2 ± 1.0 pg/mg of tissue wet weight) or RMCPII (0.9 ± 0.08 ng/mg of tissue wet weight) as compared with levels of vehicle-injected control animals (9.6 ± 1.5 pg/mg and 0.74 ± 0.1 ng/mg of tissue wet weight for PGE2 and RMCPII, respectively).
Lack of Effect of the NT Antagonist on Stress-Mediated Effects in Colonic Transit. Immobilization stress for 30 min resulted in a 9-fold increase in fecal pellet output as compared with that for control rats (n = 8 per group, P < 0.01). Pretreatment with the NT antagonist (n = 7) did not significantly inhibit the stress-mediated increase in fecal pellet output after restraint stress (data not shown). 3 . Effect of the NT antagonist SR 48692 on stress-induced PGE2 release from rat colon. Rats were injected with either saline or SR 48692 as described in the Fig. 1 legend. Rats were then immobilized, whereas control rats moved freely in their cages. After 30 min, rats were killed, colon was removed, and colonic explants (n = 3) were placed in organ culture dishes and incubated (at 37°C for 2 h) in modified Kreb's buffer (26) . One hundred-microliter aliquots of medium were collected and PGE2 levels were measured by an immunoenzymatic assay as described. Results are expressed as picograms of PGE2 released in the medium per milligram of tissue wet weight. Each bar represents the mean ± SEM of 6-10 different experiments, each with duplicate determinations. +, P < 0.05 versus control; *, P < 0.05 versus stress. Fig. 1 legend. After 30 min, immobilization rats were killed, colon was removed, and colonic explants (n = 3) were placed in organ culture dishes and incubated (at 37°C for 2 h) in modified Kreb's buffer (26) . RMCPII was measured in 100-,ul aliquots of the organ culture medium by a sandwich enzyme-linked immunosorbent assay. Each bar represents the mean ± SEM of 6-10 different experiments, each with duplicate determinations. +, P < 0.05 versus control; *, P < 0.05 versus stress.
Immobilization Stress Decreases the Abundance of NTR mRNA in Rat Colon. Hybridization of control colonic tissues with an anti-sense riboprobe encoding part of the NT receptor mRNA shows the presence of intense signal for the NTR mRNA in the epithelial cells of control rats (Fig. Sa) . There was very little signal present when control tissues were hybridized with a sense riboprobe encoding for the NTR mRNA (Fig.  Sc) . In tissues taken from rats exposed to immobilization stress (Fig. Sb) , there was a quantifiable decrease in the abundance of NTR mRNA compared with that in tissues from nonimmobilized rats. The distribution of the message in the colonic epithelial cells is uneven with a higher concentration in a subpopulation of cells in the surface epithelium (Fig. Sa) . Detectable signal is also present in the muscularis layer as well as in cells of the lamina propria. Semiquantitative analysis of the images obtained from the in situ hybridization experiments using computer-aided microdensitometry showed that immobilization stress significantly reduced the NTR mRNA labeling intensity by approximately 40% (Fig. 6 , P < 0.03).
DISCUSSION
We have previously reported an increase in mucin secretion and PGE2 release and mast cell degranulation in the rat colon in response to immobilization stress (15) . The data presented here, which show that pretreatment of rats with a NT antagonist inhibits these colonic responses, indicate that an NTdependent pathway is involved in these responses to stress.
Although our data provide evidence that NT mediates, at least in part, the colonic responses to stress, the pathways by which NT participates in stress-mediated colonic responses remain to be elucidated. NT may be released from intestinal and nonintestinal sites during stress. A high concentration of NT-like immunoreactivity is present in rat ileum localized in specialized mucosal endocrine cells (5) , whereas lower concentrations are present in the colon (2) . In addition, NT is present in high concentrations in the hypothalamus (2, 30) and has access to the general circulation. Indeed, an increase in the abundance of NT mRNA in the paraventricular nucleus of the hypothalamus has been reported after immobilization stress (19 Multiple cell types may be the site(s) of action of NT in the periphery or the central nervous system. One of these sites may be the mucosal mast cell, because pretreatment with the NT antagonist reduced stress-mediated release of RMCPII from rat colonic explants after immobilization stress (Fig. 4) . Previous results showed that NT directly activated connective tissue mast cells to release histamine in vitro and in vivo (32) .
The observation reported in this paper that epithelial cells in the colon have NTR mRNA (Fig. 5) raises the interesting possibility that NT can act directly on the colon. Tanaka et al. (33) showed by Northern blot analysis the presence of NT receptor mRNA in rat brain and large and small intestine. The presence of NT receptors also has been indicated in mucinsecreting colonic cell lines. Our in situ hybridization experiments also indicate a different distribution in the NT mRNA between the surface and the crypt colonic epithelial cells with a higher concentration of message in surface epithelial cells (Fig. 5) . This is particularly interesting in view of our data ( (Fig. 6) . Multiple mechanisms may underlie this Proc. Natl. Acad. Sci. USA 93 (1996) Proc. Natl. Acad. decrease, including a change in the stability of the message or a change in its transcription.
Previous studies showed that administration of the peptide corticotropin-releasing factor (CRF), either parenterally or into the cerebral ventrical of the paraventricular nucleus of the hypothalamus, in freely moving rats mimicked the effect of stress on intestinal motility (14, 23) . Also, administration of a CRF antagonist either i.v. or into the cerebrospinal fluid reduces the increased colonic transit caused by stress (23, 34) . We have shown that in addition to motility changes, restraint stress causes colonic mucin and PGE2 release and activates colonic mucosal mast cells (15) . These colonic changes were mimicked by i.v. or intracerebral injection of CRF in conscious, nonstressed rats and inhibited by pretreatment with the CRF antagonist a-helical CRF9_41 (15) . In this report, although administration of a NT antagonist did not reduce colonic motility as measured by fecal pellet output, it inhibited the other colonic responses caused by i.v. CRF administration (35) . It may be that the NT-dependent pathway(s) in these CRF-mediated responses occurs locally within the colon. However, in relation to the data presented here that the NT antagonist inhibits colonic responses to immobilization stress, the antagonist may act to prevent CRF secretion from the hypothalamus. In this context, it is important to know that there is a wealth of data showing anatomic localization of NT and its receptor in a number of hypothalamic sites (36, 37) critical for the regulation of CRF secretion.
